Free Newsletter
Mail-order patients go generic
Here's an unlikely enemy for brand-name drugmakers: mail-order pharmacies. Patients who fill their scrips via mail order are much more likely to choose generic drugs, according to two new studies. The exact figure was 34 percent more likely, which study sponsor Express Scripts hailed as a money-saver, but Pharma might lament as a revenue-drainer.
Two pieces of good news, though. The study only covered blood pressure meds, so generic choice might vary for other therapeutic classes. And if patients do order brand-name drugs via mail order, they're likely to be repeat customers. Compliance among mail-order patients was a full seven percentage points higher than among those who use retail pharmacies.
- read the Express Scripts release
Related Articles:
The specter of generic competition grows
Analysts get bullish on generics makers
Drug lobby stalls pro-generics bill
Say goodbye to Big Pharma's gilded age
Express Scripts mounts hostile offer for CaremarkRx (June 2006)
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession






SHARE
WITH: